The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Structural and biological mimicry of protein surface recognition by α/β-peptide foldamers
Open accessAbstract
Unnatural oligomers that can mimic protein surfaces offer a potentially useful strategy for blocking biomedically important protein-protein interactions. Here we evaluate an approach based on combining α- and β-amino acid residues in the context of a polypeptide sequence from the HIV protein gp41, which represents an excellent testbed because of the wealth of available structural and biological information. We show that α/β-peptides can mimic structural and functional properties of a critical gp41 subunit. Physical studies in solution, crystallographic data, and results from cell-fusion and virus-infectivity assays collectively indicate that the gp41-mimetic α/β-peptides effectively block HIV-cell fusion via a mechanism comparable to that of gp41-derived α-peptides. An optimized α/β-peptide is far less susceptible to proteolytic degradation than is an analogous α-peptide. Our findings show how a two-stage design approach, in which sequence-based α→β replacements are followed by site-specific backbone rigidification, can lead to physical and biological mimicry of a natural biorecognition process.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gellman, S. H. (1998) · Accounts of Chemical Research · doi:10.1021/ar960298r · Cited by 2,506
Self-citationHill, D. J., Mio, M. J., Prince, R. B., Hughes, T. S., & Moore, J. S. (2001) · Chemical Reviews · doi:10.1021/cr990120t · Cited by 2,239
Self-citationProtein Therapeutics: A Summary and Pharmacological Classification
Leader, B., Baca, Q. J., & Golan, D. E. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2399 · Cited by 2,161 · cited 2×
“At the clinical level, the most successful approach involves the use of engineered proteins or protein fragments (2).”
BackgroundCore Structure of gp41 from the HIV Envelope Glycoprotein
Chan, D. C., Fass, D., Berger, J. M., & Kim, P. S. (1997) · Cell · doi:10.1016/s0092-8674(00)80205-6 · Cited by 1,959
Small-molecule inhibitors of protein–protein interactions: progressing towards the dream
Arkin, M. R., & Wells, J. A. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1343 · Cited by 1,705 · cited 1×
“Protein-protein associations are often resistant to inhibition by small molecules because the contact surfaces on the natural partners are large (1).”
BackgroundSpin glasses and the statistical mechanics of protein folding.
Bryngelson, J. D., & Wolynes, P. G. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7524 · Cited by 1,634
Atomic structure of the ectodomain from HIV-1 gp41
Weissenhorn, W., Dessen, A., Harrison, S. C., Skehel, J. J., & Wiley, D. C. (1997) · Nature · doi:10.1038/387426a0 · Cited by 1,622
Wei, X., Decker, J. M., Liu, H., Zhang, Z., Arani, R. B., Kilby, J. M., Saag, M. S., Wu, X., Shaw, G. M., & Kappes, J. C. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.6.1896-1905.2002 · Cited by 1,569 · cited 3×
“Briefly, TZM-bl cells were seeded the day before inoculation at a density of 105 cells per mL, 100 L per well.”
MethodInfluentialChange in Coreceptor Use Correlates with Disease Progression in HIV-1–Infected Individuals
Connor, R. I., Sheridan, K. E., Ceradini, D., Choe, S., & Landau, N. R. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.4.621 · Cited by 1,353
Mechanisms of Viral Membrane Fusion and Its Inhibition
Eckert, D. M., & Kim, P. S. (2001) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.70.1.777 · Cited by 1,282
Foldamers as versatile frameworks for the design and evolution of function
Goodman, C. M., Choi, S., Shandler, S., & DeGrado, W. F. (2007) · Nature Chemical Biology · doi:10.1038/nchembio876 · Cited by 899
Residue-based control of helix shape in β-peptide oligomers
Appella, D. H., Christianson, L. A., Klein, D. A., Powell, D. R., Huang, X., Barchi, J. J., & Gellman, S. H. (1997) · Nature · doi:10.1038/387381a0 · Cited by 626
Self-citationChemical etiology of nucleic acid structure
Eschenmoser, A. (1999) · Science · doi:10.1126/science.284.5423.2118 · Cited by 611
Atomic structure of a thermostable subdomain of HIV-1 gp41
Tan, K., Liu, J.-H., Wang, J.-H., Shen, S., & Lu, M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.23.12303 · Cited by 532
Self-citationEvidence that a prominent cavity in the coiled coil of HIV type 1 gp41 is an attractive drug target
Chan, D. C., Chutkowski, C. T., & Kim, P. S. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15613 · Cited by 477
Foldamers: Structure, Properties, and Applications
(2007) · Wiley eBooks · doi:10.1002/9783527611478 · Cited by 467
Enfuvirtide: the first therapy to inhibit the entry of HIV-1 into host CD4 lymphocytes
Matthews, T., Salgo, M., Greenberg, M., Chung, J., DeMasi, R., & Bolognesi, D. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1331 · Cited by 465
Eckert, D. M., Malashkevich, V. N., Hong, L. H., Carr, P. A., & Kim, P. S. (1999) · Cell · doi:10.1016/s0092-8674(00)80066-5 · Cited by 442
The HIV Env-mediated fusion reaction
Gallo, S. A., Finnegan, C. M., Viard, M., Raviv, Y., Dimitrov, A., Rawat, S. S., Puri, A., Durell, S., & Blumenthal, R. (2003) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(03)00161-5 · Cited by 391
Helical β-Peptide Inhibitors of the p53-hDM2 Interaction
Kritzer, J. A., Lear, J. D., Hodsdon, M. E., & Schepartz, A. (2004) · Journal of the American Chemical Society · doi:10.1021/ja031625a · Cited by 314
β-Amino Acids: Versatile Peptidomimetics
Steer, D., Lew, R., Perlmutter, P., Smith, A., & Aguilar, M.-I. (2002) · Current Medicinal Chemistry · doi:10.2174/0929867024606759 · Cited by 279
The entry of entry inhibitors: A fusion of science and medicine
Moore, J. P., & Doms, R. W. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1932511100 · Cited by 278
Self-citationTerphenyl‐Based Helical Mimetics That Disrupt the p53/HDM2 Interaction
Yin, H., Lee, G., Park, H. S., Payne, G. A., Rodriguez, J. M., Sebti, S. M., & Hamilton, A. D. (2005) · Angewandte Chemie International Edition · doi:10.1002/anie.200462316 · Cited by 255
Development of a Potent Bcl-xLAntagonist Based on α-Helix Mimicry
Kutzki, O., Park, H. S., Ernst, J. T., Orner, B. P., Yin, H., & Hamilton, A. D. (2002) · Journal of the American Chemical Society · doi:10.1021/ja026861k · Cited by 253
Potent D-peptide inhibitors of HIV-1 entry
Welch, B. D., VanDemark, A. P., Heroux, A., Hill, C. P., & Kay, M. S. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708109104 · Cited by 250
Dwyer, J. J., Wilson, K. L., Davison, D. K., Freel, S. A., Seedorff, J. E., Wring, S. A., Tvermoes, N. A., Matthews, T. J., Greenberg, M. L., & Delmedico, M. K. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701478104 · Cited by 238
Designing polymers that mimic biomolecules
KIRSHENBAUM, K., ZUCKERMANN, R., & DILL, K. (1999) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(99)80075-x · Cited by 210
β-Peptides as Inhibitors of Small-Intestinal Cholesterol and Fat Absorption
Werder, M., Hauser, H., Abele, S., & Seebach, D. (1999) · Helvetica Chimica Acta · doi:10.1002/(sici)1522-2675(19991006)82:10<1774::aid-hlca1774>3.0.co;2-o · Cited by 209
Helix Bundle Quaternary Structure from α/β-Peptide Foldamers
Horne, W. S., Price, J. L., Keck, J. L., & Gellman, S. H. (2007) · Journal of the American Chemical Society · doi:10.1021/ja070396f · Cited by 200
Self-citationMechanism of Membrane Fusion by Viral Envelope Proteins
Harrison, S. C. (2005) · Advances in Virus Research · doi:10.1016/s0065-3527(05)64007-9 · Cited by 199
Short constrained peptides that inhibit HIV-1 entry
Sia, S. K., Carr, P. A., Cochran, A. G., Malashkevich, V. N., & Kim, P. S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.232566599 · Cited by 195
Louwagie, J., Janssens, W., Mascola, J., Heyndrickx, L., Hegerich, P., van der Groen, G., McCutchan, F. E., & Burke, D. S. (1995) · Journal of Virology · doi:10.1128/jvi.69.1.263-271.1995 · Cited by 192
Inhibiting HIV Fusion with a β-Peptide Foldamer
Stephens, O. M., Kim, S., Welch, B. D., Hodsdon, M. E., Kay, M. S., & Schepartz, A. (2005) · Journal of the American Chemical Society · doi:10.1021/ja053444+ · Cited by 174
Sadowsky, J. D., Schmitt, M. A., Lee, H.-S., Umezawa, N., Wang, S., Tomita, Y., & Gellman, S. H. (2005) · Journal of the American Chemical Society · doi:10.1021/ja053678t · Cited by 173
Self-citationErnst, J. T., Kutzki, O., Debnath, A. K., Jiang, S., Lu, H., & Hamilton, A. D. (2002) · Angewandte Chemie International Edition · doi:10.1002/1521-3773(20020118)41:2<278::aid-anie278>3.0.co;2-a · Cited by 172
Trkola, A., Ketas, T., KewalRamani, V. N., Endorf, F., Binley, J. M., Katinger, H., Robinson, J., Littman, D. R., & Moore, J. P. (1998) · Journal of Virology · doi:10.1128/jvi.72.3.1876-1885.1998 · Cited by 160
Self-citationSequence‐Based Design of α/β‐Peptide Foldamers That Mimic BH3 Domains
Horne, W. S., Boersma, M., Windsor, M. A., & Gellman, S. H. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200705315 · Cited by 154
Self-citationSmall molecules that bind the inner core of gp41 and inhibit HIV envelope-mediated fusion
Frey, G., Rits‐Volloch, S., Zhang, X.-Q., Schooley, R. T., Chen, B., & Harrison, S. C. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601036103 · Cited by 135
Horne, W. S., Price, J. L., & Gellman, S. H. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801135105 · Cited by 124
Self-citationRational Development of β-Peptide Inhibitors of Human Cytomegalovirus Entry
English, E. P., Chumanov, R. S., Gellman, S. H., & Compton, T. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m508485200 · Cited by 101
Self-citationInhibition of HIV‐1 Fusion by Hydrogen‐Bond‐Surrogate‐Based α Helices
Wang, D., Lu, M., & Arora, P. S. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200704227 · Cited by 89
Self-citationSadowsky, J., Murray, J. K., Tomita, Y. A., & Gellman, S. H. (2007) · ChemBioChem · doi:10.1002/cbic.200600546 · Cited by 79
Self-citationProtein Design of a Bacterially Expressed HIV-1 gp41 Fusion Inhibitor
Deng, Y., Zheng, Q., Ketas, T. J., Moore, J. P., & Lu, M. (2007) · Biochemistry · doi:10.1021/bi7001289 · Cited by 46
Self-citationArylamide Derivatives as Peptidomimetic Inhibitors of Calmodulin
Yin, H. H., Frederick, K. K., Liu, D., et al. (2005) · Organic Letters · doi:10.1021/ol052478j · Cited by 39
Cited by
Guichard, G., & Huc, I. (2011) · Chemical Communications · doi:10.1039/c1cc11137j · Cited by 769
Inhibition of α-helix-mediated protein–protein interactions using designed molecules
Azzarito, V., Long, K., Murphy, N. S., & Wilson, A. J. (2013) · Nature Chemistry · doi:10.1038/nchem.1568 · Cited by 727
Pelay‐Gimeno, M., Glas, A., Koch, O., & Grossmann, T. N. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201412070 · Cited by 717
Modulators of Protein–Protein Interactions
Milroy, L.-G., Grossmann, T. N., Hennig, S., Brunsveld, L., & Ottmann, C. (2014) · Chemical Reviews · doi:10.1021/cr400698c · Cited by 497
Peptidic foldamers: ramping up diversity
Martinek, T. A., & Fülöp, F. (2012) · Chem. Soc. Rev. · doi:10.1039/c1cs15097a · Cited by 485
Metadata
- Authors
- Horne, W. S., Johnson, L. M., Ketas, T. J., Klasse, P. J., Lu, M., Moore, J. P., & Gellman, S. H.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2009-09
- Volume
- 106
- Issue
- 35
- Pages
- 14751-14756
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2050486326
- Cited by
- 275
- References
- 44
- FWCI
- 9.72
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.